Difference between revisions of "Team:Sheffield/episode9"

(Created page with "<html> <head> <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1"> <met...")
 
 
(20 intermediate revisions by 6 users not shown)
Line 24: Line 24:
 
                 <script  
 
                 <script  
 
                   src="https://2016.igem.org/Template:Sheffield/scripts/banner?action=raw&ctype=text/javascript"></script>
 
                   src="https://2016.igem.org/Template:Sheffield/scripts/banner?action=raw&ctype=text/javascript"></script>
−
               
 
 
                 <script  
 
                 <script  
−
                   src="https://2016.igem.org/Template:Sheffield/scripts/jquery-ui?action=raw&ctype=text/javascript"></script>
+
                  src="https://2016.igem.org/Template:Sheffield/scripts/backtotopbutton?action=raw&ctype=text/javascript"></script>
 +
                <script
 +
                   src="https://2016.igem.org/Template:Sheffield/scripts/jquery-ui?action=raw&ctype=text/javascript"></script>
 +
                <script
 +
                  src="https://2016.igem.org/Template:Sheffield/scripts/popover?action=raw&ctype=text/javascript"> </script>
 
<style type="text/css">
 
<style type="text/css">
 
     #top_title, #sideMenu{
 
     #top_title, #sideMenu{
Line 107: Line 110:
 
         <div class="navbar-header">
 
         <div class="navbar-header">
 
           <div class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar">
 
           <div class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar">
−
             <img src="https://static.igem.org/mediawiki/2016/1/18/T--Sheffield--navbar-logo.png">
+
             <img src="https://static.igem.org/mediawiki/2016/a/a5/T--Sheffield--Website-home-mobile.png">
 
           </div>
 
           </div>
 
           <!-- <a class="navbar-brand" href="#">Igem Sheff 16</a> -->  
 
           <!-- <a class="navbar-brand" href="#">Igem Sheff 16</a> -->  
Line 120: Line 123:
 
<th>
 
<th>
 
<div class="navimagediv">
 
<div class="navimagediv">
−
<a href="intro_template.html"><img src="https://static.igem.org/mediawiki/2016/1/18/T--Sheffield--navbar-logo.png"></a>
+
<a href="https://2016.igem.org/Team:Sheffield"><img src="https://static.igem.org/mediawiki/2016/1/18/T--Sheffield--navbar-logo.png"></a>
 
</div>
 
</div>
 
</th>
 
</th>
Line 126: Line 129:
 
             </li>
 
             </li>
 
    <li class="dropdown" id="li-home">
 
    <li class="dropdown" id="li-home">
−
               <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false" >
+
               <a href="https://2016.igem.org/Team:Sheffield" >
 
  <center>
 
  <center>
 
<table id="navtable">
 
<table id="navtable">
Line 145: Line 148:
 
             </li> 
 
             </li> 
 
             <li class="dropdown">
 
             <li class="dropdown">
−
              <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false" >
+
            <a href="https://2016.igem.org/Team:Sheffield/Description" class="dropdown-toggle" >
 
  <center>
 
  <center>
 
<table id="navtable">
 
<table id="navtable">
Line 166: Line 169:
 
              
 
              
 
             <li class="dropdown">
 
             <li class="dropdown">
−
               <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false" >
+
               <a href="https://2016.igem.org/Team:Sheffield/project" class="dropdown-toggle" >
 
  <center>
 
  <center>
 
<table id="navtable">
 
<table id="navtable">
Line 187: Line 190:
 
 
 
<li class="dropdown">
 
<li class="dropdown">
−
               <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false" >
+
               <a href="https://2016.igem.org/Team:Sheffield/Team" class="dropdown-toggle" >
 
  <center>
 
  <center>
 
<table id="navtable">
 
<table id="navtable">
Line 208: Line 211:
 
            
 
            
 
<li class="dropdown">
 
<li class="dropdown">
−
               <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false" >
+
               <a href="https://2016.igem.org/Team:Sheffield/Notebook" class="dropdown-toggle" >
 
  <center>
 
  <center>
 
<table id="navtable">
 
<table id="navtable">
Line 229: Line 232:
 
              
 
              
 
             <li class="dropdown">
 
             <li class="dropdown">
−
               <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false" >
+
               <a href="https://2016.igem.org/Team:Sheffield/judging" class="dropdown-toggle" >
 
  <center>
 
  <center>
 
<table id="navtable">
 
<table id="navtable">
Line 261: Line 264:
 
</th>
 
</th>
 
<th>
 
<th>
−
<div class="heading-title"><h1 style="padding:0px">OUTREACH</h1></div>
+
<div class="heading-title"><h1 style="padding:0px">THE FUTURE</h1></div>
 
</th>
 
</th>
 
<th class="banner-img">
 
<th class="banner-img">
Line 268: Line 271:
 
</table>
 
</table>
 
</div>
 
</div>
−
                 <table id="banner-section">
+
                  
−
<tr>
+
−
<th>
+
−
<div class="banner-hold">
+
−
<img src="https://static.igem.org/mediawiki/2016/5/5e/T--Sheffield--banner-hold.png">
+
−
</div>
+
−
</th>
+
−
<th>
+
−
<div class="banner-hold">
+
−
<img src="https://static.igem.org/mediawiki/2016/5/5e/T--Sheffield--banner-hold.png">
+
−
</div>
+
−
</th>
+
−
<th>
+
−
<div class="banner-hold">
+
−
<img src="https://static.igem.org/mediawiki/2016/5/5e/T--Sheffield--banner-hold.png">
+
−
</div>
+
−
</th>
+
−
<th>
+
−
<div class="banner-hold">
+
−
<img src="https://static.igem.org/mediawiki/2016/5/5e/T--Sheffield--banner-hold.png">
+
−
</div>
+
−
</th>
+
−
<th>
+
−
+
−
</th>
+
−
</tr>
+
−
<tr>
+
−
<td>
+
−
<table class="banner-inside">
+
−
<th>
+
−
<div class="cont button1">
+
−
<div class="banner">
+
−
<p>STUDENTS</p>
+
−
</div>
+
−
</div>
+
−
</th>
+
−
</table>
+
−
</td>
+
−
<td>
+
−
<table class="banner-inside">
+
−
<th>
+
−
<div class="cont button2">
+
−
<div class="banner">
+
−
<p>ADVISORS</p>
+
−
</div>
+
−
</div>
+
−
</th>
+
−
</table>
+
−
</td>
+
−
<td>
+
−
<table class="banner-inside">
+
−
<th>
+
−
<div class="cont button3">
+
−
<div class="banner">
+
−
<p>SUPERVISORS</p>
+
−
</div>
+
−
</div>
+
−
</th>
+
−
</table>
+
−
</td>
+
−
<td>
+
−
                                                <table class="banner-inside">
+
−
<th>
+
−
<div class="cont button3">
+
−
<div class="banner">
+
−
<p>ACKNOWDLEDGEMENTS</p>
+
−
</div>
+
−
</div>
+
−
</th>
+
−
</table>
+
−
+
−
</td>
+
−
<td>
+
−
+
−
</td>
+
−
</tr>
+
−
</table>
+
 
<div class = "jumbotron">
 
<div class = "jumbotron">
−
<p>SCIENCE! and other stuff </p>
+
 +
 
 +
<h2>Introducing our device to the market</h2>
 +
 
 +
<p>Misusing antibiotics and manufacturing a device incur costs. The costs of mass producing a device should be less than the costs involved in misusing antibiotics, for the device to have commercial viability in the real world. This could be modelled by taking into account the cost of materials and distribution of a device, and comparing this to the effect antibiotic resistance and misprescription has on a system such as the <button class="btn btn-lg btn-danger" data-placement="top" data-toggle="popover" title="National Health Service" data-content="The free health institutional service in Britain">NHS</button>.</p>
 +
 
 +
<p>If our device were to become a widespread diagnostic tool, it would require approval from regulatory authorities such as National Institute for Health and Care Excellence (NICE), the Medicines and Healthcare products Regulatory Agency (MHRA) and the International Organisation for Standardization (ISO). Further, we would need to wait for rulings from UK and EU government commissions concerning whether <button class="btn btn-lg btn-danger" data-placement="top" data-toggle="popover" title="Genetically Modified" data-content="containing genetic material that has been artificially altered so as to produce a desired characteristic.">GM</button> live bacteria could be safely distributed within a healthcare setting.</p>
 +
 
 +
<p>Public and private healthcare providers such as the National Health Service (NHS) and British United Provident Association (Bupa) should be consulted as these would be the end-users. We could further improve the device by conducting widespread trials in partnership with our end-users.</p>
 +
 
 
</div>
 
</div>
 
     </div>
 
     </div>
Line 355: Line 292:
 
      
 
      
 
      
 
      
−
   
+
<div class="glossary"><a href="https://2016.igem.org/Team:Sheffield/glossary"><img src="https://static.igem.org/mediawiki/2016/8/86/T--Sheffield--Glossary.png"></a></div>
 +
<div class="backToTop"><img src="https://static.igem.org/mediawiki/2016/5/55/T--Sheffield--TopArrow.png"></div>   
 
      
 
      
 
</body>
 
</body>
  
 
</html>
 
</html>

Latest revision as of 21:18, 19 October 2016

A template page

THE FUTURE

Introducing our device to the market

Misusing antibiotics and manufacturing a device incur costs. The costs of mass producing a device should be less than the costs involved in misusing antibiotics, for the device to have commercial viability in the real world. This could be modelled by taking into account the cost of materials and distribution of a device, and comparing this to the effect antibiotic resistance and misprescription has on a system such as the .

If our device were to become a widespread diagnostic tool, it would require approval from regulatory authorities such as National Institute for Health and Care Excellence (NICE), the Medicines and Healthcare products Regulatory Agency (MHRA) and the International Organisation for Standardization (ISO). Further, we would need to wait for rulings from UK and EU government commissions concerning whether live bacteria could be safely distributed within a healthcare setting.

Public and private healthcare providers such as the National Health Service (NHS) and British United Provident Association (Bupa) should be consulted as these would be the end-users. We could further improve the device by conducting widespread trials in partnership with our end-users.